Etude
Oedème maculaire et occlusions veineuses
In the French clinical setting, DEX implant demonstrated efficacy and safety similar to those of phase 3 trials.
BCVA significantly increased at all follow-up visits
CRT was reduced at all follow-up visits
DEX implant was well tolerated
The most frequently reported AEs were cataract and IOP increase, consistent with previous observations
...